Grafts of stem-cell-derived precursors of dopamine neurons could be used to treat Parkinson'
s disease, but this approach has limitations. Injecting a growth factor three weeks after transplantation can overcome some of these limits.
Steps to improve function and survival of dopamine-neuron transplants.
